Orchard Therapeutics plc
ORTXDelisted Jan 24, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001748907
Orchard Therapeutics plc was delisted on Jan 24, 2024; its insiders filed their last Form 4 on Jan 24, 2024; 47 institutions reported holding it in 13F filings for Q4 2023, worth $122.0M in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Orchard Therapeutics plc changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 85 | 1 | 79 | −5 |
| Shares | 79.9M | 108.0K | 72.7M | −7.10M (−8.9%) |
| Value | $350.8M | $475.0K | $167.4M | −$183.0M (−52.2%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held Orchard Therapeutics plc at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Eversept Partners, LP | 569,581 | $1.31M | 0.11% |
| Gsa Capital Partners LLP | 374,811 | $862.0K | 0.09% |
| Woodline Partners LP | 361,736 | $832.0K | 0.01% |
| Marshall Wace, LLP | 157,194 | $361.0K | 0.00% |
| Marshall Wace North America L.P. | 46,371 | $107.0K | 0.00% |
| Altium Wealth Management LLC | 22,000 | $51.0K | 0.00% |
| HRT Financial LP | 20,504 | $47.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 17,572 | $40.0K | 0.00% |
| Spears Abacus Advisors LLC | 15,400 | $35.0K | 0.00% |
| Jane Street Group, LLC | 12,597 | $29.0K | 0.00% |
| HCR Wealth Advisors | 10,000 | $23.0K | 0.00% |
| Quantbot Technologies LP | 3,300 | $7.00K | 0.00% |
Sold out (17)
Institutions that held Orchard Therapeutics plc at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Lord, Abbett & Co. LLC | 1,626,603 | $7.14M |
| Sphera Funds Management Ltd. | 1,366,564 | $6.00M |
| Baker Bros. Advisors LP | 1,192,003 | $5.23M |
| Massachusetts Financial Services Co | 500,256 | $2.20M |
| Qube Research & Technologies Ltd | 94,492 | $415.0K |
| Wellington Management Group LLP | 82,589 | $363.0K |
| Victory Capital Management Inc | 77,236 | $339.0K |
| Vident Investment Advisory, LLC | 43,810 | $192.0K |
| Geode Capital Management, LLC | 32,748 | $143.0K |
| Northern Trust Corp | 26,049 | $114.0K |
| Dynamic Technology Lab Private Ltd | 18,538 | $81.0K |
| Kestra Private Wealth Services, LLC | 15,355 | $67.0K |
| Altfest L J & Co Inc | 12,397 | $54.0K |
| Fox Run Management, L.L.C. | 10,247 | $45.0K |
| Federation des caisses Desjardins du Quebec | 1,094 | $4.80K |
| Larson Financial Group LLC | 328 | $1.00K |
| State of Wyoming | 62 | $0 |
Not filed for Q3 2021 yet (1)
Institutions that held Orchard Therapeutics plc at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| QS Investors, LLC | 108,000 | $475.0K |